StockWatch
·
Pharmaceuticals
Clarification11 Nov 2026, 11:12 am

Sun Pharma Advanced Research Confirms Regulatory Compliance

AI Summary

Sun Pharma Advanced Research Company Ltd has responded to a clarification sought by BSE Limited, confirming its compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated that all required disclosures have been made to the exchanges and that it is unaware of any undisclosed material information. Sun Pharma Advanced Research reiterated its commitment to timely and adequate disclosures as per applicable regulations.

Key Highlights

  • Company confirms compliance with SEBI Listing Regulations.
  • All required disclosures have been made to stock exchanges.
  • No undisclosed material information is known.
  • Commitment to timely and adequate disclosures reaffirmed.